Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $24,540 | $28,318 | $28,541 | $34,124 | $45,043 |
| Gross Profit | $19,057 | $21,006 | $21,912 | $27,042 | $36,624 |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Net Income | $6,194 | $5,582 | $6,245 | $5,240 | $10,590 |
Over the past five years, Eli Lilly’s revenue and gross profit have consistently increased, indicating robust top-line growth and efficient cost management in generating profit from sales. Revenue grew from approximately $24.5 billion in 2020 to nearly $45.0 billion in 2024, with the most substantial jump occurring between 2023 and 2024—a roughly 32% increase—suggesting an acceleration in sales possibly driven by successful product launches or expanded market penetration. Gross profit followed a similar upward trend, rising from about $19.1 billion in 2020 to $36.6 billion in 2024, which reflects the company’s ability to maintain healthy margins even as revenues expanded. It is noteworthy that operating income is consistently reported as zero, which means that either operating income is not being captured in these data points or it is being reported by an atypical accounting practice; thus, analysis on operating performance must rely on other indicators. Net income presents a somewhat mixed picture over the period. After peaking at approximately $6.2 billion in 2020, net income dipped in 2021 to around $5.6 billion and experienced fluctuations through 2023 before rebounding sharply to $10.6 billion in 2024—a significant year-over-year swing of over 100%. This variability in net income may reflect changes in non-operating items, tax benefits, or one-off events rather than a pure change in operational performance. Overall, based on the revenue and gross profit expansion, Eli Lilly appears financially robust with strong sales momentum and profit generation. However, the irregular net income trend and absence of operating income data suggest that further investigation would be prudent to fully assess underlying profitability drivers and sustainability in future periods.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.